Literature DB >> 12016371

Transient peritumoral enhancement during dynamic MRI of the liver: cavernous hemangioma versus hepatocellular carcinoma.

Jeong-Sik Yu1, Ki Whang Kim, Mi-Suk Park, Sang-Wook Yoon.   

Abstract

PURPOSE: The purpose of this work was to compare the incidence and pattern of transient peritumoral parenchymal enhancement for cavernous hemangioma and hepatocellular carcinoma during dynamic MRI of the liver.
METHOD: Two hundred seven hemangiomas and 155 hepatocellular carcinomas up to 4 cm in size were retrospectively assessed. The peritumoral enhancement was comparatively analyzed in terms of the shape, extent, signal intensity, and dependence on the size and degree of contrast enhancement of each tumor.
RESULTS: For small lesions (<2 cm), hemangiomas (16/141; 11.3%) showed a higher incidence (p = 0.026) of peritumoral enhancement than hepatocellular carcinomas (3/87; 3.5%). For larger lesions (2-4 cm), there was no significant difference (p > 0.05) in the incidence of peritumoral enhancement of hemangiomas (15/66; 22.7%) and hepatocellular carcinomas (15/68; 22.1%). Nineteen (61.3%) of the 31 hemangiomas showed contrast agent filling the entire tumor volume at the phase of peritumoral enhancement.
CONCLUSION: In spite of the limited specificity, for a <2 cm small focal lesion with homogeneous contrast enhancement on early phase dynamic MR images in the liver, peritumoral enhancement could suggest a higher possibility of hemangioma rather than hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016371     DOI: 10.1097/00004728-200205000-00016

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.

Authors:  Jiae Choi; Jeong-Sik Yu; Eun-Suk Cho; Joo Hee Kim; Jae-Joon Chung
Journal:  Radiol Med       Date:  2018-01-22       Impact factor: 3.469

Review 2.  Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis.

Authors:  Filipe Caseiro-Alves; Jorge Brito; Antonio Eiras Araujo; Pedro Belo-Soares; Henrique Rodrigues; Augusta Cipriano; Daniel Sousa; Didier Mathieu
Journal:  Eur Radiol       Date:  2007-01-27       Impact factor: 5.315

Review 3.  Multimodal MRI contrast agents.

Authors:  Luca Frullano; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2007-07-21       Impact factor: 3.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.